Cargando…

Novel Receptor for Advanced Glycation End Products‐Blocking Antibody to Treat Diabetic Peripheral Artery Disease

BACKGROUND: Expression of receptor for advanced glycation end products (RAGE) plays an important role in diabetic peripheral artery disease. We proposed to show that treatment with an antibody blocking RAGE would improve hind limb perfusion and muscle viability in diabetic pig with femoral artery (F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Lynne L., Johnson, Jordan, Ober, Rebecca, Holland, April, Zhang, Geping, Backer, Marina, Backer, Joseph, Ali, Ziad, Tekabe, Yared
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955479/ https://www.ncbi.nlm.nih.gov/pubmed/33327730 http://dx.doi.org/10.1161/JAHA.120.016696

Ejemplares similares

VEGF receptor targeted imaging of angiogenic response to limb ischemia in diabetic vs. non-diabetic Yucatan minipigs
por: Johnson, Lynne L., et al.
Publicado: (2020)

Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia
por: Tekabe, Yared, et al.
Publicado: (2013)

Imaging VEGF receptor expression to identify accelerated atherosclerosis
por: Tekabe, Yared, et al.
Publicado: (2014)

Blocking RAGE improves wound healing in diabetic pigs
por: Johnson, Jordan M, et al.
Publicado: (2022)

Blocking RAGE expression after injury reduces inflammation in mouse model of acute lung injury
por: Johnson, Lynne L., et al.
Publicado: (2023)

Beneficial Effect of Glucose Control on Atherosclerosis Progression in Diabetic ApoE(−/−) Mice: Shown by Rage Directed Imaging
por: Tekabe, Yared, et al.
Publicado: (2014)

Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes
por: Tekabe, Yared, et al.
Publicado: (2011)

Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes
por: Helleputte, Simon, et al.
Publicado: (2022)

Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors
por: Jaggupilli, Appalaraju, et al.
Publicado: (2019)

Increased expression of the receptor for advanced glycation end-products in human peripheral neuropathies
por: Juranek, Judyta K, et al.
Publicado: (2013)

Glycation end-products specific auto-antibodies in Systemic Lupus Erythematosus
por: Ali Khan, Mohd Wajid
Publicado: (2022)

Historical Note on the Concept of Arterial Hypertension
por: Backer, Marcus
Publicado: (1944)

Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs
por: Johnson, Lynne L, et al.
Publicado: (2014)

Commentary: A twist on pulmonary artery translocation
por: Backer, Carl L.
Publicado: (2021)

Imaging Key Biomarkers of Tumor Angiogenesis
por: Backer, Marina V., et al.
Publicado: (2012)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease
por: Woźniak, Marcin, et al.
Publicado: (2021)

Sodium bicarbonate to prevent cardiac surgery-associated kidney injury: the end of a dream?
por: Hougardy, Jean-Michel, et al.
Publicado: (2012)

Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology
por: Meloche, Jolyane, et al.
Publicado: (2013)

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
por: Liu, Jhih-Syuan, et al.
Publicado: (2015)

The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study
por: Malmstedt, Jonas, et al.
Publicado: (2015)

An Aptamer-Based Antagonist against the Receptor for Advanced Glycation End-Products (RAGE) Blocks Development of Colorectal Cancer
por: Zheng, Jihui, et al.
Publicado: (2021)

Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease
por: Finco, Alessandra Becker, et al.
Publicado: (2016)

Relevance of Receptor for Advanced Glycation end Products (RAGE) in Murine Antibody-Mediated Autoimmune Diseases
por: Eichhorst, Alexandra, et al.
Publicado: (2019)

Hesperetin treatment attenuates glycation of lens proteins and advanced‑glycation end products generation
por: Doki, Yuri, et al.
Publicado: (2023)

Glycosylated hemoglobin, but not advanced glycation end products, predicts severity of coronary artery disease in patients with or without diabetes
por: Basman, Craig, et al.
Publicado: (2020)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
por: Papagrigoraki, Anastasia, et al.
Publicado: (2017)

Toxicity of advanced glycation end products (Review)
por: Kuzan, Aleksandra
Publicado: (2021)

Advanced Glycation End Products in Health and Disease
por: Reddy, V. Prakash, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Single-photon emission computed tomography/computed tomography imaging of RAGE in smoking-induced lung injury
por: Goldklang, Monica P., et al.
Publicado: (2019)

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
por: Wang, Xiangming, et al.
Publicado: (2019)

Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome
por: Willemsen, Suzan, et al.
Publicado: (2011)

High Serum Advanced Glycation End-Products Predict Coronary Artery Disease Irrespective of Arterial Stiffness in Diabetic Patients
por: Won, Ki-Bum, et al.
Publicado: (2012)

A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer
por: Wendel, Ulrika, et al.
Publicado: (2018)

Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study — protocol for a multicentre cross-sectional study
por: de Vos, L C, et al.
Publicado: (2017)

The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis
por: Atzeni, Isabella M., et al.
Publicado: (2023)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mctuuvru4upmgnrq54k51vokvg